|
SHARING MAKES US STRONG TOGETHER #CORONAHELP
|
|
Now more than ever, the importance of collaboration, sharing and transparency in supply and demand, becomes more clear. On the one hand, many companies and organizations have a great demand for materials, tools, manpower, and other forms of capacity. On the other hand, there is a great willingness within many companies and organizations to help where it's possible.
That is exactly what we can help with at FLOOW2: making demand as well as supply visible and matchable online. How? Via a smart sharing marketplace solution that suits your company, organization, or network. |
|
|
FREE SHARING SCAN
CALCULATE WHAT YOU CAN EARN OR SAVE
|
|
Are you curious to find out how sharing assets, materials, services, facilities and personnel can be beneficial for your company or organization? Start the free SharingScan and: - Calculate your potential revenue and cost savings.
- Calculate your potential energy and CO2 savings
- Gain insight into which assets, services and facilities generate the highest returns.
|
|
|
MEDICINE MARKETPLACE SAVES THOUSANDS OF EUROS
|
|
Wastage of medication is a hotly debated issue. It is estimated that in the Netherlands alone, they throw away at least 100 million Euros’ worth of medicines every year. PharmaSwap is a unique sharing marketplace for pharmacists in The Netherlands, hospital-based, or otherwise, that creates transparency in the supply and demand for expensive medicines.
During 2019 a pilot was conducted over 6 months in which 20 pharmacists took part. As a result of this pilot, the destruction of 68 packages was avoided; instead they were re-issued to patients. These 68 packages represent a total procurement value of Euro 54,000.
Currently (May 2020) 145 pharmacists are using the PharmaSwap platform. Many medicines have been shared and the transaction value from January 1st 2020 till now has been calculated on 61.000 Euro. The currently offered medicines on the platform represent a procurement value of 145.000 Euro. With 2,000 pharmacies in the Netherlands alone, these results indicate the magnitude of the circular impact PharmaSwap can achieve if rolled out on a large scale. |
|
|
|
